C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
12/2002
12/26/2002	US20020197241 Compositions for regenerating tissue that has deteriorated, and methods for using such compositions
12/26/2002	US20020197240 Marrow stem cell (MSC) transplantation for use in tissue and/or organ repair
12/26/2002	US20020197239 Methods and devices for the long-culture of hematopoietic progenitor cells
12/26/2002	US20020197238 Platelet derived growth factor (PDGF)-derived neurospheres define a novel class of progenitor cells
12/26/2002	US20020197237 Adeno-associated virus vectors
12/26/2002	US20020197234 Immunologic activities of rhesus cytomegalovirus encoded IL-10 and human cytomegalovirus encoded IL-10
12/26/2002	US20020197232 Methods for using the obese gene and its gene product to stimulate hematopoietic development
12/26/2002	CA2391568A1 Collapsin response mediator protein-1
12/25/2002	CN1387576A Sequence-specific DNA recombination in ekaryotic cells
12/25/2002	CN1387575A Method for transfer of molecular substances with prokaryontic nucleic acid-binding proteins
12/25/2002	CN1387571A Mammalian cytokines, related reagents and methods
12/25/2002	CN1387569A Apoptin-associating protein
12/25/2002	CN1387565A Hematopoietic differentiation of human embryonic stem cells
12/25/2002	CN1387539A Human monoclonal antibodies to prostate specific membrane antigen
12/25/2002	CN1387537A Pharmaceutical compositions and methods of using secreted frizzled related protein
12/25/2002	CN1387536A T2R-novel family of taste receptors
12/25/2002	CN1387401A Use of haploid genomes for genetic diagnosis, modification and multiplication
12/25/2002	CN1386848A Human cerebral transfer cell line of lung cancer
12/24/2002	US6498233 Nucleic acid transfer system
12/24/2002	US6498149 Culturing human placental decidua derived cells with surface markers as positive cd57 and bright hla.dr; 1-dehydroxy-2-(1-guanine, 1-uracil or 1-(7-ketopurine))ribofuranose deri-vatives; reduced side effects
12/24/2002	US6498138 Method of promoting production of living tissue equivalents
12/24/2002	US6498034 Culturing cd34 positive progenitor cells in presence of cytokines, tumor necrosis factor, colony stimulating factor, and transforming growth factor to generate cd1a and lag reactive dendritic cells
12/24/2002	US6498033 Retroviral vector with gag gene sequence containing packaging signal; human immunodeficiency virus treatment; vaccines; gene therapy; anticarcinogenic agents
12/24/2002	US6498025 Methods and compositions for cDNA synthesis
12/24/2002	US6498022 Isolated nucleic acid molecules encoding human carbonate transporter proteins, and uses thereof
12/24/2002	US6498018 Cultures of human CNS neural stem cells
12/24/2002	US6498011 Method for transformation of animal cells
12/24/2002	US6498007 Methods of treatment of disease using adsorbent carriers
12/24/2002	US6498006 Administering mixture of liposome and drug
12/24/2002	US6497879 Composition which comprises isolated mage-10 tumor rejection antigen precursor which is encoded by nucleic acid having specified nucleotide sequence
12/24/2002	US6497876 Method of stimulating an immune response with activated dendritic cells
12/24/2002	US6497875 Multilayer skin equivalent consisting of scaffold layer incorporated with dermis-forming cells consisting of mesenchymal stem cells, and keratinocyte layer; treating burns and ulcers
12/24/2002	US6497872 Neural transplantation using proliferated multipotent neural stem cells and their progeny
12/24/2002	US6497871 Polypeptide having anti-viral and anti-proliferative activity
12/24/2002	CA2086264C Surface complexed lymphotoxin
12/24/2002	CA2061636C Chimeric gene for the transformation of plants
12/24/2002	CA2042093C Cell line carrying an excess of mammalian centromeres
12/19/2002	WO2002101388A2 Assay for predeicting cell activity
12/19/2002	WO2002101385A1 In vivo bioreactors
12/19/2002	WO2002101075A2 Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
12/19/2002	WO2002101074A2 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines
12/19/2002	WO2002101070A2 Alpha 2 integrin: modulators of lymphocyte activation
12/19/2002	WO2002101069A2 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders
12/19/2002	WO2002101060A1 Processes and vectors for producing transgenic plants
12/19/2002	WO2002101059A2 Transgenic plants synthesising high amylose starch
12/19/2002	WO2002101052A2 Salutaridinol 7-o-acetyltransferase and derivatives thereof
12/19/2002	WO2002101048A2 NEW POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-7 GENE
12/19/2002	WO2002101046A1 Monoclonal antibody binding to mt4-mmp catalytic domain
12/19/2002	WO2002101045A2 Vanilloid receptor-related nucleic acids and polypeptides
12/19/2002	WO2002101044A2 Brain expressed gene and protein associated with bipolar disorder
12/19/2002	WO2002101031A1 Cyp450-specific dna probes and primers, and biological applications thereof
12/19/2002	WO2002101030A1 Method f0r the isolation of a cluster of cells from an isolated organ
12/19/2002	WO2002101029A1 Method of separating and concentrating cells for kidney regfneration
12/19/2002	WO2002101028A2 Biomaterial substrates
12/19/2002	WO2002101019A2 Methods of culturing animal cells and polypeptide production in animal cells
12/19/2002	WO2002101018A2 Methods for inducing reversible stasis
12/19/2002	WO2002101009A2 Structural and cytoskeleton-associated proteins
12/19/2002	WO2002101008A2 Intracellular signaling molecules
12/19/2002	WO2002101005A2 A g-protein coupled receptor and uses therefor
12/19/2002	WO2002100998A2 Method for generating diversity
12/19/2002	WO2002100898A2 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell and hematopoietic progenitor cell, and dna coding for the same
12/19/2002	WO2002100890A2 Respiratory syncytial virus
12/19/2002	WO2002100889A1 Novel epitope of human papilloma virus e7 antigen and cd4-positive t cells activated by the epitope
12/19/2002	WO2002100827A2 Method for increasing the survival of dopamine secreting cells
12/19/2002	WO2002100406A1 Use of yohimbine in the preparation of immunobiologically active drugs
12/19/2002	WO2002100348A2 Human monoclonal antibodies to epidermal growth factor receptor (egfr)
12/19/2002	WO2002100335A2 Methods for improving cell line activity in immunoisolation devices
12/19/2002	WO2002100324A2 Compositions and methods for the repair and construction of bone and other tissue
12/19/2002	WO2002100250A2 Wit 3.0, a novel gene to control soft tissue wound healing
12/19/2002	WO2002087341A9 Novel self-inactivating (sin) lentiviral vectors
12/19/2002	WO2002081677A3 Improved gene expression
12/19/2002	WO2002076288A3 Biodegradable, electrically conductiong polymer for tissue engineering applications
12/19/2002	WO2002070565A3 High-affinity antagonists of elr-cxc chemokines
12/19/2002	WO2002070561A3 Nuclear hormone receptor ligand binding domain
12/19/2002	WO2002070560A3 Nuclear hormone receptor ligand binding domain
12/19/2002	WO2002070558A3 Nuclear hormone receptor ligand binding domain
12/19/2002	WO2002068603A3 Materials and methods for the induction of premature chromosome condensation
12/19/2002	WO2002066603A3 Chemically defined medium for cultured mammalian cells
12/19/2002	WO2002064755A3 Post-partum mammalian placenta, its use and placental stem cells therefrom
12/19/2002	WO2002053176A3 An autologous anti-cancer vaccine
12/19/2002	WO2002050104A9 Methods and cells for detecting modulators of rgs proteins
12/19/2002	WO2002033111A3 Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues
12/19/2002	WO2002029014A3 Stem cell differentiation-inducing promoter
12/19/2002	WO2002024727A3 New inhibitors of iapp fibril formation and uses thereof
12/19/2002	WO2002012338A3 Screening method
12/19/2002	WO2002008287A3 Nk cells activating receptors and their therapeutic and diagnostic uses
12/19/2002	WO2002004665A3 Method with a wide range of applications, for identifying modulators of g-protein-coupled receptors
12/19/2002	WO2001077169A9 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
12/19/2002	WO2001075087A3 Subtilisin variants
12/19/2002	WO2001075077A8 Isolation and expression of a gene for a nitrilase from acidovorax facilis 72w
12/19/2002	WO2001072994A9 Human urothelial cell specific uroplakin transcriptional regulatory sequences, vectors comprising the same, and methods of use thereof
12/19/2002	WO2001072977A9 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
12/19/2002	WO2001068859A9 Il-17 receptor like molecules and uses thereof
12/19/2002	US20020194649 Process for production and subsequent ex vitro sowing and propagation of pre-germinated plant somatic embryos
12/19/2002	US20020194644 Method for increasing stress-resistance to a plant
12/19/2002	US20020194642 Nucleotide sequences coding enzymatic polypeptide for use in the generation of disease resistant plants
12/19/2002	US20020194641 PUFA polyketide synthase systems and uses thereof
12/19/2002	US20020194638 Vector for genetically modifying non-human animals
12/19/2002	US20020194637 Generation of genetic engineered embryonic stem cells for use in the treatment of parkinson's, huntington's, alzheimer's, diabetes, multiple sclerosis, muscular, bone and liver disorders
12/19/2002	US20020194633 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis

1 ... 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 1281 1282 1283 1284 1285 ... 1827